Kimia Biosciences Ltd Financials

Kimia Biosciences Ltd Financial Statement

Kimia Biosciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	28.55	22.48	30.60
Operating Expense	24.81	18.69	26.14
Net Profit	1.61	1.44	1.80
Net Profit Margin	5.64	6.41	5.88
Earning Per Share	0.34	0.30	0.38
EBIDTA	3.76	3.75	3.96
Effective Tax Rate	8.56	7.92	TBA

Particulars	Sep 2024
Revenue	28.55
Operating Expense	24.81
Net Profit	1.61
Net Profit Margin	5.64
Earning Per Share	0.34
EBIDTA	3.76
Effective Tax Rate	8.56

Kimia Biosciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	104.88	128.52	124.90
Operating Expenses Annual	105.36	133.49	124.27
Operating Profit Annual	1.16	-4.81	1.56
Interest Annual	5.05	4.25	3.64
Depreciation	3.24	3.27	2.90
Net Profit Annual	-5.31	-9.35	-3.70
Tax Annual	-1.88	-3.04	-1.32

Particulars	Mar 2024
Total Revenue Annual	104.88
Operating Expenses Annual	105.36
Operating Profit Annual	1.16
Interest Annual	5.05
Depreciation	3.24
Net Profit Annual	-5.31
Tax Annual	-1.88

Kimia Biosciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.18	0.20	0.59
Cash Flow from Operations	14.53	-6.77	8
Cash Flow from Investing	-1.49	-2.80	-0.71
Cash Flow from Financing	-13.07	9.54	-7.67
Cash Flow at the End	0.15	0.18	0.20

Particulars	Mar 2024
Cash Flow at the Beginning	0.18
Cash Flow from Operations	14.53
Cash Flow from Investing	-1.49
Cash Flow from Financing	-13.07
Cash Flow at the End	0.15

Kimia Biosciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	1.11	-3.74	1.25
PBIT Margin (%)	-2.03	-6.33	-1.10
PBT Margin (%)	-1.63	-4.84	-0.80
Net PROFIT Margin (%)	-5.06	-7.28	-2.96
Return On Networth / Equity (%)	TBA	TBA	-22.20
Return On Networth /Employed (%)	TBA	TBA	-2.03
Return On Assets (%)	-8.86	-14.26	-5.45
Total Debt / Equity (X)	16.69	4.60	2.57
Asset Turnover Ratio (%)	1.75	1.96	1.84

Particulars	Mar 2024
PBDIT Margin (%)	1.11
PBIT Margin (%)	-2.03
PBT Margin (%)	-1.63
Net PROFIT Margin (%)	-5.06
Return On Networth / Equity (%)	TBA
Return On Networth /Employed (%)	TBA
Return On Assets (%)	-8.86
Total Debt / Equity (X)	16.69
Asset Turnover Ratio (%)	1.75

Kimia Biosciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	31.85	33.63	35.23
Total Current Assets Annual	61.41	82.75	73.07
Non Current Assets Annual	38.56	38.57	36.42
Total Shareholders Funds Annual	0.33	5.46	14.89
Total Assets Annual	99.97	121.32	109.49

Particulars	Mar 2024
Fixed Assets Annual	31.85
Total Current Assets Annual	61.41
Non Current Assets Annual	38.56
Total Shareholders Funds Annual	0.33
Total Assets Annual	99.97

Kimia Biosciences Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Jan 15, 2025, Kimia Biosciences Ltd has a market capitalization of 263.67 Cr. Value Research classifies it as a Small-Cap company.

No, Kimia Biosciences Ltd is not debt-free with a debt-to-equity ratio of 132.05.

In FY 2024 , Kimia Biosciences Ltd recorded a total revenue of approximately 104.88 Cr marking a significant milestone in the company's financial performance.

Kimia Biosciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and -0.1% annually, respectively..

Kimia Biosciences Ltd's current PE ratio is -49.66.

Kimia Biosciences Ltd's ROCE averaged -6.3% from the FY ending March 2022 to 2024, with a median of -4.2%. It peaked at -2.2% in March 2022, reflecting strong capital efficiency over the period..

Kimia Biosciences Ltd's latest EBIT is Rs. -2.13 Cr, surpassing the average EBIT of Rs. -3.88 Cr over the 5 years..